Previous Article | Next Article ![]()
J. Virol., 01 1997, 84-94, Vol 71, No. 1
Y Gao, PR Smith, L Karran, QL Lu and BE Griffin
An Epstein-Barr virus transcript (designated D-HIT [Daudi high-level-
inducible transcript]), constitutively expressed at low levels in the
Burkitt's lymphoma (BL)-derived cell line Daudi, can be induced with
tetradecanoylphorbol acetate or n-butyrate or, in combination, to about 1%
of the levels of high-molecular-weight RNAs in cells. The transcript can
also be induced in some other EBV-positive BL-derived cells but to a much
lesser extent, particularly in lines that can give rise to productive
infection. D-HIT is viral in origin and is composed largely of repetitive
sequence. It is polyadenylated but mainly nuclear in location and is highly
structured, sensitive only to double-strand- specific RNase. It is
endogenously expressed in interferon-sensitive Daudi strains but not in an
insensitive strain, Daudi 100K. D-HIT contains a part of a viral open
reading frame (designated LF3, and deleted in the prototype B95-8 strain),
using an internal polyadenylation (AAUAAA) sequence as a signal to specify
processing of its 3' end. In Daudi cells, the promoter contains a putative
hinge structure, as found in some interferon-inducible genes and c-myc.
Since D-HIT lies adjacent to, probably even encompassing, one of the two
viral lytic origins (D(R)) of replication, it may have a role in the
regulation of DNA replication. Alternatively, or in addition via its
double-stranded structure, D-HIT may play a regulatory role in interferon
pathways. Its promoter could be of value for studying expression in
constructions containing heterologous genes.
Copyright © 1997, American Society for Microbiology
Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi
Department of Virology, Royal Postgraduate Medical School, London, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|